ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip 美国 - 英文 - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

SODIUM CHLORIDE 10 % W/V B.P.88 injection. 埃及 - 英文 - EDA (Egyptian Drug Authority)

sodium chloride 10 % w/v b.p.88 injection.

otsuka egypt - infusion - 10 %

SODIUM CHLORIDE 10 % W/V B.P.88 injection. 埃及 - 英文 - EDA (Egyptian Drug Authority)

sodium chloride 10 % w/v b.p.88 injection.

otsuka egypt - infusion - 10 %

DNS - Sodium Chloride and Glucose Intravenous Infusion BP (0.9% wv & 5% wv) 马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dns - sodium chloride and glucose intravenous infusion bp (0.9% wv & 5% wv)

biocare pharmaceutical (m) sdn. bhd. - sodium chloride; anhydrous glucose -

5% DEXTROSE AND 0.9% SOD.CHLORIDE* 马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

5% dextrose and 0.9% sod.chloride*

luen wah medical co. sdn. bhd. - sodium chloride (salt); dextrose, anhydrous/anhydrous glucose -

OTSU-NS 0.9% SODIUM CHLORIDE INTRAVENOUS INFUSION BP 马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

otsu-ns 0.9% sodium chloride intravenous infusion bp

luen wah medical co. sdn. bhd. - sodium chloride (salt) -

Lactec Injection (250mL) (ラクテック注（250mL）) 日本 - 英文 - すりの適正使用協議会 RAD-AR Council, Japan

lactec injection (250ml) (ラクテック注（250ml）)

otsuka pharmaceutical factory, inc. - sodium l-lactate; sodium chloride; potassium chloride; calcium chloride hydrate - injection

Lactec Injection (500mL) (ラクテック注（500mL）) 日本 - 英文 - すりの適正使用協議会 RAD-AR Council, Japan

lactec injection (500ml) (ラクテック注（500ml）)

otsuka pharmaceutical factory, inc. - sodium l-lactate; sodium chloride; potassium chloride; calcium chloride hydrate - injection

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% INJECTION USP 新加坡 - 英文 - HSA (Health Sciences Authority)

dextrose 5% and sodium chloride 0.9% injection usp

luen wah medical company (singapore) private limited - dextrose; sodium chloride - injection - 5 g/100 ml - dextrose 5 g/100 ml; sodium chloride 0.9 g/100 ml

None 0.90% Intravenous Injection 菲律宾 - 英文 - FDA (Food And Drug Administration)

none 0.90% intravenous injection

otsuka (philippines) pharmaceutical inc.; distributor: otsuka (philippines) pharmaceutical inc. - sodium chloride - intravenous injection - 0.90%